Best Value Stocks to Buy (2024)

Procter & Gamble

• Sector: Consumer staples
• Market value: $356.5 billion
• Dividend yield: 2.5%

When it comes to reliable revenue, consumer products icon Procter & Gamble (PG, $151.24) is the envy of Wall Street. Its massive portfolio of in-demand brands includes Gillette razors, Tide and Downy detergents, Crest toothpaste, Bounty and Charmin paper products, and a host of others. These goods are on the weekly shopping lists of many consumers, and are likely to stay there regardless of the ups and downs of the broader economy.

And it's not just U.S. shoppers we're talking about, either, as P&G operates in about 70 countries worldwide.

Thanks to this steady sales engine, P&G also offers reliable dividends – and consistent growth in that payout to boot. Specifically, Procter & Gamble boasts a stunning 67 consecutive years where it has increased its dividend payouts, the most recent occurring in mid-April when it hiked its quarterly dividend by 3%.

P&G also said it expects to pay around $9 billion in total dividends and repurchase as much as $6 billion of its own stock in fiscal 2024 as part of its continued commitment to shareholder value. Though growth is admittedly modest in the consumer staples businesses of P&G, you can't argue that this is one of the best value stocks for investors.

JPMorgan Chase

• Sector: Financial services
• Market value: $444.9 billion
• Dividend yield: 2.7%

JPMorgan Chase (JPM, $153.19) is the largest U.S. bank by market value, as well as the largest bank by deposits with some $3.2 trillion in assets under management. You won't find a more stable mainstay among financial stocks than JPM.

The firm is well established and well respected, with roots of the company dating back to 1799. The bank has weathered many storms over those years, including being the first to bounce back from the financial crisis of 2008. And in fact, it is the only one of the "Big Four" financials that has seen both its share price and dividend payouts eclipse where they were before the Great Recession and housing crash gutted the sector.

More recently, JPM showed it is the go-to name for depositors as it gained a massive $50 billion in deposits at the end of March 2023, according to its first-quarter earnings report, driven by fear over failures in the sector like Silicon Valley Bank.

No wonder the long-term price performance of JPM is steadily higher, across all manner of market disruptions. With a dividend yield that is nearly twice that of the broader S&P 500 and a brand that is one of the most respected in the sector, this megabank is one of the best value stocks that long-term investors can believe in.

Coca-Cola

• Sector: Consumer staples
• Market value: $252.8 billion
• Dividend yield: 3.2%

One of the most recognizable brands on the planet, Coca-Cola (KO, $58.46) has more than 120 years of operating history and a rock-solid global operation that has withstood the test of time. That was certainly true in 2022, when the Dow stock posted a total return (price return + dividends) of 10.6% vs an 18.1% decline for the S&P 500.

KO's durability is also supported by the fact that the iconic investor Warren Buffett of Berkshire Hathaway (BRK.B) has been a longtime proponent of co*ke. KO has been a member of the Berkshire Hathaway equity portfolio since the late 1980s. What's more, the holding company is Coca-Cola's largest shareholder at present, with a stake of more than 9%.

It's easy to see why, as Buffett tends to be drawn to long-term value stocks that pay generous dividends and offer stable returns. That's Coca-Cola in a nutshell. Its most recent dividend hike in February brought KO's streak of raising its payout to 61 years.

With long-term stability and a reliable dividend, this is exactly the kind of value stock that investors want to put their money behind for the long run – just as Warren Buffett has done.

Johnson & Johnson

• Sector: Healthcare
• Market value: $364.2 billion
• Dividend yield: 3.2%

Though it sounds morbid, Johnson & Johnson (JNJ, $151.28) has long been known as a "widow-and-orphan" stock on Wall Street. These investments get their name because they typically pay a generous dividend and offer generally low-risk returns, meaning that on the chance the household breadwinners die unexpectedly, their widow and/or children will be provided for.

That may be an old fashioned notion, but considering Johnson & Johnson was founded back in 1886, there's probably good reason this term has stuck around. Over the intervening years, JNJ has delivered on this promise of stability and consistency, too, and is now one of the 15 largest U.S. stocks, with a market cap of $3640billion.

The company has a massive consumer brand portfolio that includes Tylenol and Band-Aid products – a division that's now its own separate company following the impressive May initial public offering (IPO) of Kenvue (KVUE).

As a result, JNJ is now focused on its largest line: its pharmaceutical segment that includes prescription drugs to treat cancer, arthritis and other conditions. You may also remember that JNJ was one of the leading COVID-19 vaccine providers a few years ago, with the world's first single-dose shot. On top of that, it also makes a host of medical devices including artificial joints and surgical tools. These goods are higher margin than a box of Band-Aids, to be sure, and help provide a lot more to the bottom line.

But regardless of the products you're looking at, it's undeniable that Johnson & Johnson is a top brand that healthcare professionals – as well as dividend stock investors – have come to rely on. The blue chip stock just raised its dividend payout in April for the 61st consecutive year, proving again its long-term commitment to shareholder value. This makes it one of the best value stocks to consider going forward.

Shell

• Sector: Energy
• Market value: $216.3 billion
• Dividend yield: 4.0%

Shell (SHEL, $65.81) is an international stock with headquarters in the U.K. Those who have been around a while may remember the company's former name: Royal Dutch Shell.

Regardless of which country Shell calls home, this multinational oil and gas giant is one of the most dominant energy stocks on the planet. In fact, it is currently the fourth largest energy company by market capitalization, falling behind Saudi Aramco, Exxon Mobil (XOM) and Chevron (CVX).

In the age of climate change, you might think it's hard to claim that any traditional integrated energy company is one of the best long-term value stocks. But the fact is that carbon-neutral sources are still only part of global energy production – and as of the end of 2022, Shell reported nearly 10 billion barrels of oil and equivalents in its reserves to help fuel the world during this transition.

From a long-term perspective, Shell also is worth considering for its dividend. It yields more than twice that of the S&P 500 after recently boosting its payout from 50 cents quarterly to 57.5 cents in February – an impressive 15% increase.

Plus, shares have surged nearly 16% in 2023 and have nearly doubled in the last three years, swimming upstream in what has undoubtedly been a challenging and volatile environment on Wall Street.

AT&T

• Sector: Communication services
• Market value: $115.9 billion
• Dividend yield: 6.9%

Value stocks often don't have remarkable growth stories. But what they do tend to offer is unrivaled stability and a commitment to delivering solid results and generous dividends year-in and year-out.

AT&T (T, $16.21) is the very embodiment of this approach, with a model that has what it takes to survive any short-term volatility on Wall Street or in the broader economy.

T is among the largest telecommunications companies in the world, and the number one carrier in the U.S. as measured by wireless subscriptions, with about 45% share of the market. There's a wide moat in telecom, given the very expensive nature of building a network of 5G towers, so it's highly unlikely that this top seat in the industry will change anytime soon.

Plus, AT&T is one of the top S&P 500 dividend stocks. The company boasts a generous yield and it has paid a dividend for more than three decades. T has also been known as a reliable dividend grower, barring the spinout of Warner Bros Discovery (WBD) last year that resulted in an instant reduction in both its market capitalization and dividend as a result of restructuring.

Altria Group

• Sector: Consumer staples
• Market value: $73.3 billion
• Dividend yield: 9.5%

Altria Group (MO, $41.44) is the company behind Marlboro cigarettes, Black & Mild pipe and cigar products, and smokeless tobacco like Copenhagen and Skoal. The tobacco products giant is one of the best value stocks with staying power.

Sure, its products aren't particularly healthy – and admittedly, there's not a lot of potential growth in a product category that is undeniably bad for you. But these tobacco products have incredibly reliable sales thanks to big brands and loyal customers, which supports a stable stock price and consistent dividends.

In fact, the company has logged more than 50 consecutive years of dividend increases – and that's not just a nominal payout, either. MO boasts a sustainable and generous payout that is six times the S&P 500.

Altria is a cash cow, throwing off a staggering $8.5 billion in free cash flow over the past four quarters. This has allowed it to return the majority of that back to shareholders, with about $6.7 billion in dividends over the same period.

The icing on the cake is that as a "sin stock," it sells products that its customers continue to buy across any economic environment. That makes Altria a value investment to believe in, even if Wall Street hits a snag in the months or years ahead.

Walgreens Boots Alliance

• Sector: Healthcare
• Market value: $17.4 billion
• Dividend yield: 9.6%

Though technically in the healthcare sector, Walgreens Boots Alliance (WBA, $20.11) has some consumer staples stock undertones, too, thanks to its business model that sells both prescription drugs as well as general merchandise at brick-and-mortar retail locations.

Specifically, WBA operates about 8,500 retail locations under the Walgreens and Duane Reade brands in the U.S., and about 4,000 more under the Boots, Benavides, and Ahumada brands internationally.

Increasingly, Walgreens is also getting into more direct forms of healthcare, with optical clinics and urgent care services provided in its locations.

Prescription drugs are already a very "recession-proof" business, as patients will take their medicines regardless of macroeconomic trends. But getting into these more practical forms of care make it even more likely that WBA will continue to put up consistent results.

Admittedly, Walgreens has been under pressure in 2023, due in part as a pullback in consumer spending has weighed on financial results.

But long-term investors should note that WBA actually beat estimates in its fiscal fourth quarter, so it may be premature to paint all drugstore chains with a broad brush.

Related content

• Best Long-Term Investment Stocks to Buy
• How To Use Sector Rotation In Investing